每年研究產出
每年研究產出
- 2結果
搜尋結果
-
2022
Corrigendum: Urine soluble CD163 is a promising biomarker for the diagnosis and evaluation of lupus nephritis(Front. Immunol., (2022), 13, (935700), 10.3389/fimmu.2022.935700)
Huang, Y. J., Lin, C. H., Yang, H. Y., Luo, S. F. & Kuo, C. F., 29 08 2022, 於: Frontiers in Immunology. 13, 1003761.研究成果: 期刊稿件 › 評論/辯論
開啟存取1 引文 斯高帕斯（Scopus） -
2020
Erratum: Statin use and risk of joint replacement due to osteoarthritis and rheumatoid arthritis: A propensity-score matched longitudinal cohort study (Rheumatology DOI: 10.1093/rheumatology/keaa223)
Sarmanova, A., Doherty, M., Kuo, C., Wei, J., Abhishek, A., Mallen, C., Zeng, C., Wang, Y., Lei, G. & Zhang, W., 01 10 2020, 於: Rheumatology (United Kingdom). 59, 10, p. 3120 1 p.研究成果: 期刊稿件 › 評論/辯論
開啟存取2 引文 斯高帕斯（Scopus）